Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 3909-3914, September 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lumelsky, N. L.
Right arrow Articles by Schwartz, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lumelsky, N. L.
Right arrow Articles by Schwartz, B. S.

Protease Inhibitors Induce Specific Changes in Protein Tyrosine Phosphorylation That Correlate with Inhibition of Apoptosis in Myeloid Cells1

Nadya L. Lumelsky and Bradford S. Schwartz2

Department of Medicine, Section of Hematology, University of Wisconsin, and William Middleton Veteran Affairs Hospital, Madison, Wisconsin 53706

To investigate early signaling events responsible for regulation of programmed cell death or apoptosis, we studied campothecin (a topoisomerase I inhibitor)-mediated apoptosis in the human promyelocytic leukemia cell line HL60. We demonstrate a tight correlation between protection of HL60 cells from apoptosis-associated internucleosomal DNA fragmentation by specific protease inhibitors or protein phosphatase inhibitors, with early tyrosine phosphorylation of a single protein substrate with a molecular weight of approximately 42,000. Exposure to protease inhibitors that did not protect HL60 cells from DNA fragmentation did not result in phosphorylation of this substrate. Likewise, a protein tyrosine kinase inhibitor that did not interfere with specific phosphorylation did not prevent DNA fragmentation. Taken together, these results suggest that phosphorylation of a Mr 42,000 substrate constitutes an important signaling event that may participate in regulation of the apoptotic response.

1 This work was supported by a University of Wisconsin Medical School Research Committee Grant 161-9851 (to N. L. L.) and by USPHS Grant HL 43506 and a Veterans Administration merit review grant (to B. S. S.).

2 To whom requests for reprints should be addressed, at Department of Medicine, Section of Hematology, 1300 University Ave., 2640 MSC, Madison, WI 53706. Phone: (608) 265-2700; Fax: (608) 263-4969; E-mail: lumelsky@facstaff.wisc.edu.

Received 3/12/96. Accepted 7/ 1/96.




This article has been cited by other articles:


Home page
J. Immunol.Home page
E. Bryl, A. N. Vallejo, C. M. Weyand, and J. J. Goronzy
Down-Regulation of CD28 Expression by TNF-{alpha}
J. Immunol., September 15, 2001; 167(6): 3231 - 3238.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.